Results 11 to 20 of about 481,186 (302)

Vaginal microbiota transplantation alleviates vaginal atrophy in ovariectomized mice [PDF]

open access: yesScientific Reports
Vaginal atrophy is a prevalent symptom in menopausal women, affecting over 50% of older women and patients with loss of ovarian function. The role of factors other than estrogen, such as the vaginal microbiota (VM), in the development of vaginal atrophy ...
Zhonglei Xu   +6 more
doaj   +4 more sources

Current treatment options for postmenopausal vaginal atrophy. [PDF]

open access: yesInt J Womens Health, 2018
Vulvovaginal atrophy (VVA) is a silent epidemic that affects up to 50%–60% of postmenopausal women who are suffering in silence from this condition. Hormonal changes, especially hypoestrogenism inherent in menopause, are characterized by a variety of ...
Naumova I, Castelo-Branco C.
europepmc   +8 more sources

Efficacy of Hormonal and Nonhormonal Approaches to Vaginal Atrophy and Sexual Dysfunctions in Postmenopausal Women: A Systematic Review. [PDF]

open access: yesRev Bras Ginecol Obstet, 2022
Objective  To evaluate the efficacy of the hormonal and nonhormonal approaches to symptoms of sexual dysfunction and vaginal atrophy in postmenopausal women.
Sarmento ACA   +5 more
europepmc   +2 more sources

Reviewing the options for local estrogen treatment of vaginal atrophy

open access: goldInternational Journal of Women's Health, 2014
Sarah H Lindahl Sutter East Bay Medical Foundation, SEBMF – Diablo Division, Castro Valley, CA, USA Background: Vaginal atrophy is a chronic condition with symptoms that include vaginal dryness, pain during sex, itching, irritation, burning, and ...
Lindahl SH
doaj   +3 more sources

The Effect of Citrus Aurantium Vaginal Cream on Vaginal Atrophy in Postmenopausal Women: A Quasi-experimental Study [PDF]

open access: yesInternational Journal of Community Based Nursing and Midwifery
Background: Vulvovaginal atrophy (VVA) is a common condition and a silent epidemic affectingmany postmenopausal women who suffer from it in silence.
Homeira Asgharpoor   +4 more
doaj   +2 more sources

Effect of the Fractional CO2 Laser on the Quality of Life, General Health, and Genitourinary Symptoms in Postmenopausal Women With Vaginal Atrophy: A Prospective Cohort. [PDF]

open access: yesJ Lasers Med Sci, 2020
Introduction: After menopause women experience vaginal atrophy related to hormonal changes and estrogen deficiency. The purpose of this paper was to evaluate the effect of the fractional CO2 laser on the quality of life, vaginal atrophy symptoms, and ...
Adabi K   +4 more
europepmc   +2 more sources

Hyaluronic acid and its use in non-hormonal therapy for the treatment of vaginal atrophy and the level of awareness about the disease itself among the women from the Podkarpackie Voivodeship

open access: diamondQuality in Sport, 2023
Introduction: Hyaluronic acid is the ingredient contained in the composition that has the ability to bind water, found in the cornea, synovial fluid and cartilage stroma.
Agata Glac   +9 more
doaj   +2 more sources

The efficacy of oxytocin gel in postmenopausal women with vaginal atrophy: an updated systematic review and meta-analysis. [PDF]

open access: goldBMC Womens Health, 2023
Farahat RA   +12 more
europepmc   +5 more sources

Comparison of Anogenital Distance and Correlation with Vulvo-vaginal Atrophy: A Pilot Study on Premenopausal and Postmenopausal Women. [PDF]

open access: yesJ Menopausal Med, 2018
OBJECTIVES: Anogenital distance (AGD) represents the space between labia posterior commissure and anus. This was pilot study to investigate how menopause and so lack of oestrogens affects AGD. METHODS: A total of 109 patients were enrolled.
Domenici L   +11 more
europepmc   +3 more sources

Home - About - Disclaimer - Privacy